These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8563553)

  • 21. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
    Bekci TT; Senol T; Maden E
    J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pt NPs and DNAzyme functionalized polymer nanospheres as triple signal amplification strategy for highly sensitive electrochemical immunosensor of tumour marker.
    Chang H; Zhang H; Lv J; Zhang B; Wei W; Guo J
    Biosens Bioelectron; 2016 Dec; 86():156-163. PubMed ID: 27362254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical and immunologic diagnosis of cancer. Hepatocellular cancer.
    Hirai H
    Tumour Biol; 1987; 8(2-3):86-93. PubMed ID: 2452470
    [No Abstract]   [Full Text] [Related]  

  • 24. [Molecular markers of micrometastasis in the blood of hepatocellular carcinoma patients].
    Stokowska A; Stalke P; Bielawski KP
    Postepy Hig Med Dosw (Online); 2007 May; 61():310-9. PubMed ID: 17554234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors.
    Richie JP
    J Urol; 2014 Mar; 191(3):659. PubMed ID: 24522037
    [No Abstract]   [Full Text] [Related]  

  • 26. Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.
    Forner A; Reig M; Bruix J
    Gastroenterology; 2009 Jul; 137(1):26-9. PubMed ID: 19482098
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
    Lopez JB; Balasegaram M; Timor J; Thambyrajah V
    Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.
    Ge T; Shen Q; Wang N; Zhang Y; Ge Z; Chu W; Lv X; Zhao F; Zhao W; Fan J; Qin W
    Med Oncol; 2015 Mar; 32(3):59. PubMed ID: 25652109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
    Giannini EG; Farinati F; Trevisani F
    Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
    [No Abstract]   [Full Text] [Related]  

  • 30. Biomarkers for the early detection of cancer: an inflammatory concept.
    Roy HK; Khandekar JD
    Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302
    [No Abstract]   [Full Text] [Related]  

  • 31. Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma.
    Nitta H; Nakagawa S; Kaida T; Arima K; Higashi T; Taki K; Okabe H; Hayashi H; Hashimoto D; Chikamoto A; Ishiko T; Beppu T; Baba H
    Surg Today; 2017 Mar; 47(3):375-384. PubMed ID: 27549776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma in southern Germany: epidemiological and clinicopathological characteristics and risk factors.
    Hellerbrand C; Hartmann A; Richter G; Knöll A; Wiest R; Schölmerich J; Lock G
    Dig Dis; 2001; 19(4):345-51. PubMed ID: 11935095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical and immunologic diagnosis of cancer. Germ cell tumors.
    Schwartz MK
    Tumour Biol; 1987; 8(2-3):106-8. PubMed ID: 2452467
    [No Abstract]   [Full Text] [Related]  

  • 34. Characteristics of Hypovascular versus Hypervascular Well-Differentiated Hepatocellular Carcinoma Smaller Than 2 cm - Focus on Tumor Size, Markers and Imaging Detectability.
    Sugimoto K; Kim SR; Imoto S; Tohyama M; Kim SK; Matsuoka T; Yano Y; Kudo M; Hayashi Y
    Dig Dis; 2015 Oct; 33(6):721-7. PubMed ID: 26488580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of pancreatitis-associated protein as a serum marker of hepatocellular carcinoma: comparison with alpha-fetoprotein.
    Montalto G; Iovanna JL; Soresi M; Dusetti N; Carroccio A; Barthelemy-Bialas S; Cartabellotta A; Dagorn JC
    Oncology; 1998; 55(5):421-5. PubMed ID: 9732219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.
    Colli A; Fraquelli M; Casazza G; Massironi S; Colucci A; Conte D; Duca P
    Am J Gastroenterol; 2006 Mar; 101(3):513-23. PubMed ID: 16542288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological markers of liver cancer.
    Yuen MF; Lai CL
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):91-9. PubMed ID: 15757806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients.
    Viggiani V; Palombi S; Gennarini G; D'Ettorre G; De Vito C; Angeloni A; Frati L; Anastasi E
    Scand J Gastroenterol; 2016 Oct; 51(10):1257-62. PubMed ID: 27227515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly sensitive, label-free and real-time detection of alpha-fetoprotein using a silicon nanowire biosensor.
    Zhou F; Li Z; Bao Z; Feng K; Zhang Y; Wang T
    Scand J Clin Lab Invest; 2015 Nov; 75(7):578-84. PubMed ID: 26205419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour markers in germ cell tumours.
    Rustin GJ
    Br Med J (Clin Res Ed); 1986 Mar; 292(6522):713-4. PubMed ID: 2420408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.